This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296
Clinical trial NCT01575561 · COMPLETED
Trial details
- NCT number
- NCT01575561
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2015-07-01
- Enrollment
- 377
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.